FYI---Universal Cancer Jab: Expected in Two Years--From Health Freedoms Alliance Newsletter/Alert

[Guest guest]

I don’t know if any of you happened to see this, but I

felt it should be shared.

~~Ruth

--------------------------------------------------

LINK: http://healthfreedoms.org/2011/05/02/universal-cancer-jab-expected-in-two-years/

Universal Cancer Jab: Expected in Two Years

By FIONA MACRAE

Submitted by Lois

Rain on May 2, 2011 – 7:45 pm

A

proposed universal cancer vaccine is supposed to be available in two years. The

TeloVac jab is already in development and has been given to hundreds of British

citizens with pancreatic cancer.

Even though it’s called a vaccine, its

reported intended use will be for cancer treatment by triggering the immune

response. Results of the UK’s

largest trial of its kind won’t be available until next year, although

the jab is credited for giving pancreatic cancer patients, on average, a few

month’s to 1-2 year’s more life.

If the study is successful, prepare for it to be

a universal preventative (see below). Another reported benefit is it’s

ability to use the immune system to combat cancer supposedly without damaging

the body and causing side effects like hair loss and nausea. No known reports

of vaccine ingredients yet.

Food for thought: will the buzz about immune

response drugs propel people to look for ways to naturally use their immune

systems for cancer prevention and treatment? And, can there really be a

one-fits-all disease treatment for cancer?

~Health Freedoms

-------------------------------------------------------------------

‘Universal’ cancer jab: Vaccine that

stops all tumours in their tracks could be here in two years

By FIONA MACRAE

A ‘universal’ vaccine that could revolutionise the

treatment of cancer could be available in just two years.

The TeloVac jab is part of a new generation of drugs that use the

body’s own defences to fight the disease, stopping tumours in their

tracks.

TeloVac has already been given to hundreds of Britons with

pancreatic cancer, one of the deadliest forms of the disease.

But it is hoped it will be effective against many other tumours,

including those of the skin, lung and liver. Breast and prostate cancers may

also be within its grasp.

Together, the six forms of the disease claim more 70,000 lives a

year in the UK.

In the case of pancreatic cancer, which killed actor

Swayze, survival rates have barely improved in the past 40 years, and patients typically

die within six months of diagnosis.

Just 3 per cent survive five years, and it is the fifth biggest

cancer killer in the UK.

Although vaccines usually prevent disease, the TeloVac jab is designed as a

treatment.

Rather than attacking the cancer cells, like many existing drugs,

it harnesses the power of the immune system to fight the tumours.

It works by encouraging the immune system to seek out and destroy

an enzyme called telomerase. Found at high levels in many cancer cells,

telomerase effectively makes them immortal, allowing them to live on when

healthy cells would die – easing the growth and spread of the tumour.

In the largest trial of its kind in the UK, more than 1,000 men and women

in the late stages of pancreatic cancer are either being given the vaccine

alongside their normal drugs or treated as usual.

The results from the 53 hospitals taking part will not be

available until next year but, anecdotally, some patients credit their

participation in the trial with giving them an extra year or two of life. In

earlier, smaller trials, the vaccine gave those in the late stages of the

disease an average of an extra three months.

Neoptolemos, who is co-ordinating the large-scale British

trial, said: ‘When you have got pancreatic cancer, it is like a timebomb

in people.’

Pancreatic cancer cells are normally invisible to the immune

system but the vaccine ‘spots’ the telomerase spilling out from

them and kick-starts the fight back.

Professor Neoptolemos, of Liverpool University,

said: ‘It is like the immune system has a blindfold on and the vaccine

takes the blindfold off.’

Healthy cells escape the attack because their levels of telomerase

are too low to bother the immune system. This cuts the risk of side-effects

such as nausea and hair loss normally seen with cancer drugs.

If the latest study, which is funded by Cancer Research UK,

proves the jab’s worth, it could be available to treat advanced

pancreatic cancer by the end of 2013. In time, it could be used earlier in the

disease – and even to prevent it.

Dr Jay Sangjae Kim, the founder of GemVax, the Korean company

developing the TeloVac vaccine, said: ‘We strongly believe this has the

potential to overcome the limits of other current cancer vaccines and become

part of the standard of care not only for pancreatic cancer but for various

other types of cancers.

‘In other words, a truly “universal” vaccine

will be available in the near future.’

Professor , of Cancer Research UK, said: ‘We await the

results with interest to see if this is an effective treatment.’

By FIONA MACRAE

Source:

http://www.dailymail.co.uk/health/article-1377069/Universal-cancer-vaccine-TeloVac-arrive-years.html

[Guest guest]

I don’t know if any of you happened to see this, but I

felt it should be shared.

~~Ruth

--------------------------------------------------

LINK: http://healthfreedoms.org/2011/05/02/universal-cancer-jab-expected-in-two-years/

Universal Cancer Jab: Expected in Two Years

By FIONA MACRAE

Submitted by Lois

Rain on May 2, 2011 – 7:45 pm

A

proposed universal cancer vaccine is supposed to be available in two years. The

TeloVac jab is already in development and has been given to hundreds of British

citizens with pancreatic cancer.

Even though it’s called a vaccine, its

reported intended use will be for cancer treatment by triggering the immune

response. Results of the UK’s

largest trial of its kind won’t be available until next year, although

the jab is credited for giving pancreatic cancer patients, on average, a few

month’s to 1-2 year’s more life.

If the study is successful, prepare for it to be

a universal preventative (see below). Another reported benefit is it’s

ability to use the immune system to combat cancer supposedly without damaging

the body and causing side effects like hair loss and nausea. No known reports

of vaccine ingredients yet.

Food for thought: will the buzz about immune

response drugs propel people to look for ways to naturally use their immune

systems for cancer prevention and treatment? And, can there really be a

one-fits-all disease treatment for cancer?

~Health Freedoms

-------------------------------------------------------------------

‘Universal’ cancer jab: Vaccine that

stops all tumours in their tracks could be here in two years

By FIONA MACRAE

A ‘universal’ vaccine that could revolutionise the

treatment of cancer could be available in just two years.

The TeloVac jab is part of a new generation of drugs that use the

body’s own defences to fight the disease, stopping tumours in their

tracks.

TeloVac has already been given to hundreds of Britons with

pancreatic cancer, one of the deadliest forms of the disease.

But it is hoped it will be effective against many other tumours,

including those of the skin, lung and liver. Breast and prostate cancers may

also be within its grasp.

Together, the six forms of the disease claim more 70,000 lives a

year in the UK.

In the case of pancreatic cancer, which killed actor

Swayze, survival rates have barely improved in the past 40 years, and patients typically

die within six months of diagnosis.

Just 3 per cent survive five years, and it is the fifth biggest

cancer killer in the UK.

Although vaccines usually prevent disease, the TeloVac jab is designed as a

treatment.

Rather than attacking the cancer cells, like many existing drugs,

it harnesses the power of the immune system to fight the tumours.

It works by encouraging the immune system to seek out and destroy

an enzyme called telomerase. Found at high levels in many cancer cells,

telomerase effectively makes them immortal, allowing them to live on when

healthy cells would die – easing the growth and spread of the tumour.

In the largest trial of its kind in the UK, more than 1,000 men and women

in the late stages of pancreatic cancer are either being given the vaccine

alongside their normal drugs or treated as usual.

The results from the 53 hospitals taking part will not be

available until next year but, anecdotally, some patients credit their

participation in the trial with giving them an extra year or two of life. In

earlier, smaller trials, the vaccine gave those in the late stages of the

disease an average of an extra three months.

Neoptolemos, who is co-ordinating the large-scale British

trial, said: ‘When you have got pancreatic cancer, it is like a timebomb

in people.’

Pancreatic cancer cells are normally invisible to the immune

system but the vaccine ‘spots’ the telomerase spilling out from

them and kick-starts the fight back.

Professor Neoptolemos, of Liverpool University,

said: ‘It is like the immune system has a blindfold on and the vaccine

takes the blindfold off.’

Healthy cells escape the attack because their levels of telomerase

are too low to bother the immune system. This cuts the risk of side-effects

such as nausea and hair loss normally seen with cancer drugs.

If the latest study, which is funded by Cancer Research UK,

proves the jab’s worth, it could be available to treat advanced

pancreatic cancer by the end of 2013. In time, it could be used earlier in the

disease – and even to prevent it.

Dr Jay Sangjae Kim, the founder of GemVax, the Korean company

developing the TeloVac vaccine, said: ‘We strongly believe this has the

potential to overcome the limits of other current cancer vaccines and become

part of the standard of care not only for pancreatic cancer but for various

other types of cancers.

‘In other words, a truly “universal” vaccine

will be available in the near future.’

Professor , of Cancer Research UK, said: ‘We await the

results with interest to see if this is an effective treatment.’

By FIONA MACRAE

Source:

http://www.dailymail.co.uk/health/article-1377069/Universal-cancer-vaccine-TeloVac-arrive-years.html